These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The biological role and regulation of versican levels in cancer. Ricciardelli C; Sakko AJ; Ween MP; Russell DL; Horsfall DJ Cancer Metastasis Rev; 2009 Jun; 28(1-2):233-45. PubMed ID: 19160015 [TBL] [Abstract][Full Text] [Related]
3. Versican silencing improves the antitumor efficacy of endostatin by alleviating its induced inflammatory and immunosuppressive changes in the tumor microenvironment. Wang Z; Li Z; Wang Y; Cao D; Wang X; Jiang M; Li M; Yan X; Li Y; Liu Y; Luo F Oncol Rep; 2015 Jun; 33(6):2981-91. PubMed ID: 25872924 [TBL] [Abstract][Full Text] [Related]
4. Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M. Koyama H; Hibi T; Isogai Z; Yoneda M; Fujimori M; Amano J; Kawakubo M; Kannagi R; Kimata K; Taniguchi S; Itano N Am J Pathol; 2007 Mar; 170(3):1086-99. PubMed ID: 17322391 [TBL] [Abstract][Full Text] [Related]
6. Versican overexpression in human breast cancer lesions: known and new isoforms for stromal tumor targeting. Kischel P; Waltregny D; Dumont B; Turtoi A; Greffe Y; Kirsch S; De Pauw E; Castronovo V Int J Cancer; 2010 Feb; 126(3):640-50. PubMed ID: 19662655 [TBL] [Abstract][Full Text] [Related]
7. Host stromal versican is essential for cancer-associated fibroblast function to inhibit cancer growth. Fanhchaksai K; Okada F; Nagai N; Pothacharoen P; Kongtawelert P; Hatano S; Makino S; Nakamura T; Watanabe H Int J Cancer; 2016 Feb; 138(3):630-41. PubMed ID: 26270355 [TBL] [Abstract][Full Text] [Related]
8. Pericellular versican regulates the fibroblast-myofibroblast transition: a role for ADAMTS5 protease-mediated proteolysis. Hattori N; Carrino DA; Lauer ME; Vasanji A; Wylie JD; Nelson CM; Apte SS J Biol Chem; 2011 Sep; 286(39):34298-310. PubMed ID: 21828051 [TBL] [Abstract][Full Text] [Related]
9. Versican G1 and G3 domains are upregulated and latent transforming growth factor-β binding protein-4 is downregulated in breast cancer stroma. Takahashi Y; Kuwabara H; Yoneda M; Isogai Z; Tanigawa N; Shibayama Y Breast Cancer; 2012 Jan; 19(1):46-53. PubMed ID: 21505857 [TBL] [Abstract][Full Text] [Related]
10. Targeting of stromal versican by miR-144/199 inhibits multiple myeloma by downregulating FAK/STAT3 signalling. Gupta N; Kumar R; Seth T; Garg B; Sharma A RNA Biol; 2020 Jan; 17(1):98-111. PubMed ID: 31532704 [TBL] [Abstract][Full Text] [Related]
11. RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration. Said N; Sanchez-Carbayo M; Smith SC; Theodorescu D J Clin Invest; 2012 Apr; 122(4):1503-18. PubMed ID: 22406535 [TBL] [Abstract][Full Text] [Related]
12. The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFbeta1 in prostate cells: relevance to the accumulation of versican. Cross NA; Chandrasekharan S; Jokonya N; Fowles A; Hamdy FC; Buttle DJ; Eaton CL Prostate; 2005 May; 63(3):269-75. PubMed ID: 15599946 [TBL] [Abstract][Full Text] [Related]
13. Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Sluiter NR; de Cuba EM; Kwakman R; Meijerink WJ; Delis-van Diemen PM; Coupé VM; Beliën JA; Meijer GA; de Hingh IH; te Velde EA Clin Exp Metastasis; 2016 Apr; 33(4):297-307. PubMed ID: 26873137 [TBL] [Abstract][Full Text] [Related]
14. Immunoregulatory roles of versican proteolysis in the myeloma microenvironment. Hope C; Foulcer S; Jagodinsky J; Chen SX; Jensen JL; Patel S; Leith C; Maroulakou I; Callander N; Miyamoto S; Hematti P; Apte SS; Asimakopoulos F Blood; 2016 Aug; 128(5):680-5. PubMed ID: 27259980 [TBL] [Abstract][Full Text] [Related]
15. Versican in the Tumor Microenvironment. Papadas A; Asimakopoulos F Adv Exp Med Biol; 2020; 1272():55-72. PubMed ID: 32845502 [TBL] [Abstract][Full Text] [Related]
16. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis. Yee AJ; Akens M; Yang BL; Finkelstein J; Zheng PS; Deng Z; Yang B Breast Cancer Res; 2007; 9(4):R47. PubMed ID: 17662123 [TBL] [Abstract][Full Text] [Related]
17. Versican upregulation in Sézary cells alters growth, motility and resistance to chemotherapy. Fujii K; Karpova MB; Asagoe K; Georgiev O; Dummer R; Urosevic-Maiwald M Leukemia; 2015 Oct; 29(10):2024-32. PubMed ID: 25915825 [TBL] [Abstract][Full Text] [Related]
18. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737 [TBL] [Abstract][Full Text] [Related]
19. Versican V2 isoform enhances angiogenesis by regulating endothelial cell activities and fibronectin expression. Yang W; Yee AJ FEBS Lett; 2013 Jan; 587(2):185-92. PubMed ID: 23201264 [TBL] [Abstract][Full Text] [Related]